Avastin
Third Biosimilar to Bevacizumab Approved
The FDA approved bevacizumab-maly (Alymsys, Amneal Pharmaceuticals), a biosimilar to bevacizumab (Avastin, ...
APRIL 19, 2022
FDA Approves Avastin Plus Chemo for Certain Women With Advanced Ovarian Cancer
The FDA granted a new indication for Avastin in combination with chemotherapy, followed by Avastin as a single ...
JUNE 14, 2018
FDA Gives Full Approval to Avastin for Recurrent GBM
The FDA has granted full approval for bevacizumab (Avastin, Genentech) for the treatment of adults with ...
DECEMBER 7, 2017
Load more